ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Two Children Achieve Remission With CD19 Immunotherapy

March 29, 2013

NCAB to Get NCI Bypass Budget May 13; DeVita Tells Centers That Is Where “Our Philosophy Can Be Found”

May 3, 1985

Children’s Oncology Group Study Shows Improved Care For Childhood Brain Tumors

October 31, 2008

FDA Proposes New Nonclinical Lab Regs

November 26, 1976

IARC Publishes Fourth Edition of European Code Against Cancer

October 17, 2014

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989